nodes	percent_of_prediction	percent_of_DWPC	metapath
Bisoprolol—ADRB1—Adrenoceptors—ADRA2C—attention deficit hyperactivity disorder	0.0651	0.0665	CbGpPWpGaD
Bisoprolol—ADRB2—Adrenoceptors—ADRA2C—attention deficit hyperactivity disorder	0.0637	0.0651	CbGpPWpGaD
Bisoprolol—ADRB1—Adrenoceptors—ADRA2A—attention deficit hyperactivity disorder	0.0342	0.0349	CbGpPWpGaD
Bisoprolol—ADRB2—Adrenoceptors—ADRA2A—attention deficit hyperactivity disorder	0.0335	0.0342	CbGpPWpGaD
Bisoprolol—ADRB1—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.023	0.0235	CbGpPWpGaD
Bisoprolol—ADRB1—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.0226	0.0231	CbGpPWpGaD
Bisoprolol—ADRB2—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.0225	0.023	CbGpPWpGaD
Bisoprolol—ADRB2—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.0221	0.0225	CbGpPWpGaD
Bisoprolol—ADRB1—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.0194	0.0198	CbGpPWpGaD
Bisoprolol—ADRB1—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.019	0.0194	CbGpPWpGaD
Bisoprolol—ADRB2—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.0189	0.0193	CbGpPWpGaD
Bisoprolol—ADRB2—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.0186	0.019	CbGpPWpGaD
Bisoprolol—ADRB1—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.0137	0.014	CbGpPWpGaD
Bisoprolol—Pindolol—HTR1B—attention deficit hyperactivity disorder	0.0134	0.647	CrCbGaD
Bisoprolol—ADRB2—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.0134	0.0137	CbGpPWpGaD
Bisoprolol—ADRB1—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.0132	0.0134	CbGpPWpGaD
Bisoprolol—ADRB2—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.0129	0.0131	CbGpPWpGaD
Bisoprolol—ADRB1—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.0127	0.013	CbGpPWpGaD
Bisoprolol—ADRB2—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.0124	0.0127	CbGpPWpGaD
Bisoprolol—ADRB1—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.0123	0.0126	CbGpPWpGaD
Bisoprolol—ADRB1—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.0121	0.0124	CbGpPWpGaD
Bisoprolol—ADRB2—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.012	0.0123	CbGpPWpGaD
Bisoprolol—ADRB1—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.012	0.0122	CbGpPWpGaD
Bisoprolol—ADRB2—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.0118	0.0121	CbGpPWpGaD
Bisoprolol—ADRB2—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.0117	0.0119	CbGpPWpGaD
Bisoprolol—ADRB1—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.0115	0.0117	CbGpPWpGaD
Bisoprolol—ADRB2—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.0112	0.0115	CbGpPWpGaD
Bisoprolol—ADRB1—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.0111	0.0114	CbGpPWpGaD
Bisoprolol—ADRB2—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.0109	0.0111	CbGpPWpGaD
Bisoprolol—ADRB1—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.0107	0.0109	CbGpPWpGaD
Bisoprolol—ADRB1—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.0106	0.0108	CbGpPWpGaD
Bisoprolol—ADRB2—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.0105	0.0107	CbGpPWpGaD
Bisoprolol—ADRB1—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.0104	0.0106	CbGpPWpGaD
Bisoprolol—ADRB1—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.0102	0.0104	CbGpPWpGaD
Bisoprolol—ADRB2—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.0101	0.0103	CbGpPWpGaD
Bisoprolol—ADRB1—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.01	0.0103	CbGpPWpGaD
Bisoprolol—ADRB2—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.00995	0.0102	CbGpPWpGaD
Bisoprolol—ADRB2—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.00983	0.01	CbGpPWpGaD
Bisoprolol—ADRB1—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.00936	0.00956	CbGpPWpGaD
Bisoprolol—ADRB2—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.00916	0.00935	CbGpPWpGaD
Bisoprolol—ADRB1—G alpha (s) signalling events—DRD5—attention deficit hyperactivity disorder	0.00783	0.00799	CbGpPWpGaD
Bisoprolol—ADRB1—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.0078	0.00796	CbGpPWpGaD
Bisoprolol—ADRB2—G alpha (s) signalling events—DRD5—attention deficit hyperactivity disorder	0.00766	0.00782	CbGpPWpGaD
Bisoprolol—ADRB2—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.00763	0.00779	CbGpPWpGaD
Bisoprolol—Propranolol—HTR1B—attention deficit hyperactivity disorder	0.00733	0.353	CrCbGaD
Bisoprolol—ADRB1—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.00656	0.00669	CbGpPWpGaD
Bisoprolol—ADRB2—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.00641	0.00655	CbGpPWpGaD
Bisoprolol—ADRB2—GPCRs, Other—DRD3—attention deficit hyperactivity disorder	0.00535	0.00546	CbGpPWpGaD
Bisoprolol—CYP2D6—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.0052	0.00531	CbGpPWpGaD
Bisoprolol—ADRB2—GPCRs, Other—DRD4—attention deficit hyperactivity disorder	0.00519	0.0053	CbGpPWpGaD
Bisoprolol—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00501	0.00512	CbGpPWpGaD
Bisoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00445	0.00454	CbGpPWpGaD
Bisoprolol—ADRB1—G alpha (s) signalling events—DRD1—attention deficit hyperactivity disorder	0.00441	0.0045	CbGpPWpGaD
Bisoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00436	0.00445	CbGpPWpGaD
Bisoprolol—ADRB1—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00435	0.00445	CbGpPWpGaD
Bisoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00435	0.00444	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00432	0.00442	CbGpPWpGaD
Bisoprolol—ADRB2—G alpha (s) signalling events—DRD1—attention deficit hyperactivity disorder	0.00431	0.0044	CbGpPWpGaD
Bisoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00426	0.00435	CbGpPWpGaD
Bisoprolol—ADRB2—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00426	0.00435	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00423	0.00432	CbGpPWpGaD
Bisoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00381	0.00389	CbGpPWpGaD
Bisoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00373	0.00381	CbGpPWpGaD
Bisoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00373	0.00381	CbGpPWpGaD
Bisoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00365	0.00373	CbGpPWpGaD
Bisoprolol—ADRB2—GPCRs, Other—HTR2A—attention deficit hyperactivity disorder	0.00339	0.00346	CbGpPWpGaD
Bisoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00302	0.00308	CbGpPWpGaD
Bisoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00295	0.00302	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.0029	0.00296	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00284	0.0029	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00284	0.0029	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00278	0.00284	CbGpPWpGaD
Bisoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00264	0.0027	CbGpPWpGaD
Bisoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00259	0.00264	CbGpPWpGaD
Bisoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00258	0.00264	CbGpPWpGaD
Bisoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00253	0.00258	CbGpPWpGaD
Bisoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00245	0.00251	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00244	0.0025	CbGpPWpGaD
Bisoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.0024	0.00245	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00239	0.00244	CbGpPWpGaD
Bisoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00238	0.00243	CbGpPWpGaD
Bisoprolol—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00236	0.00241	CbGpPWpGaD
Bisoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00234	0.00239	CbGpPWpGaD
Bisoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00232	0.00237	CbGpPWpGaD
Bisoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00231	0.00236	CbGpPWpGaD
Bisoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00228	0.00233	CbGpPWpGaD
Bisoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00226	0.00231	CbGpPWpGaD
Bisoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00226	0.0023	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00222	0.00227	CbGpPWpGaD
Bisoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00221	0.00226	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00217	0.00222	CbGpPWpGaD
Bisoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00215	0.00219	CbGpPWpGaD
Bisoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.0021	0.00215	CbGpPWpGaD
Bisoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.0021	0.00215	CbGpPWpGaD
Bisoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00206	0.0021	CbGpPWpGaD
Bisoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00204	0.00208	CbGpPWpGaD
Bisoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.002	0.00204	CbGpPWpGaD
Bisoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00199	0.00203	CbGpPWpGaD
Bisoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00198	0.00202	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00197	0.00201	CbGpPWpGaD
Bisoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00196	0.002	CbGpPWpGaD
Bisoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00193	0.00197	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00193	0.00197	CbGpPWpGaD
Bisoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00184	0.00188	CbGpPWpGaD
Bisoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.0018	0.00184	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00172	0.00176	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00168	0.00172	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00164	0.00167	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00161	0.00164	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.0016	0.00164	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.0016	0.00163	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00157	0.0016	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00157	0.0016	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00155	0.00158	CbGpPWpGaD
Bisoprolol—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00154	0.00157	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00152	0.00156	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00152	0.00155	CbGpPWpGaD
Bisoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00151	0.00154	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.0015	0.00154	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00149	0.00152	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00149	0.00152	CbGpPWpGaD
Bisoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00147	0.0015	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00147	0.0015	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00146	0.00149	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00146	0.00149	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00143	0.00146	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.0014	0.00143	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00137	0.0014	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00131	0.00134	CbGpPWpGaD
Bisoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00129	0.00132	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00128	0.00131	CbGpPWpGaD
Bisoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00126	0.00129	CbGpPWpGaD
Bisoprolol—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00126	0.00129	CbGpPWpGaD
Bisoprolol—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00125	0.00128	CbGpPWpGaD
Bisoprolol—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00124	0.00127	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00111	0.00114	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00109	0.00111	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00102	0.00105	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00101	0.00103	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.001	0.00102	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000989	0.00101	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000982	0.001	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000973	0.000994	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000961	0.000981	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000952	0.000972	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000905	0.000924	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000885	0.000904	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000884	0.000902	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000879	0.000898	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000876	0.000895	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000864	0.000883	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000862	0.00088	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000861	0.000879	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00086	0.000879	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000857	0.000875	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00085	0.000869	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000845	0.000863	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000843	0.000861	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000842	0.00086	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000832	0.00085	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000826	0.000844	CbGpPWpGaD
Bisoprolol—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000824	0.000841	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000821	0.000839	CbGpPWpGaD
Bisoprolol—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000818	0.000835	CbGpPWpGaD
Bisoprolol—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000812	0.00083	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000804	0.000821	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000796	0.000812	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000792	0.000809	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000782	0.000799	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000778	0.000795	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000775	0.000791	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000772	0.000789	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000765	0.000781	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000756	0.000772	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000719	0.000735	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000704	0.000719	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000597	0.00061	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000584	0.000597	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000555	0.000567	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000543	0.000554	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000522	0.000533	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000515	0.000526	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000511	0.000521	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000504	0.000515	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000493	0.000503	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000485	0.000496	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000475	0.000485	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00047	0.00048	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000462	0.000472	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00046	0.000469	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000456	0.000466	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000452	0.000461	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000446	0.000456	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000425	0.000434	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000416	0.000425	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000356	0.000363	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000356	0.000363	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00035	0.000357	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000337	0.000344	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000325	0.000332	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000298	0.000304	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000291	0.000297	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000284	0.00029	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000271	0.000276	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000233	0.000237	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000233	0.000237	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000229	0.000234	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	0.000215	0.00022	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000214	0.000218	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000213	0.000217	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000186	0.00019	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000177	0.000181	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000158	0.000161	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000154	0.000158	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	0.000141	0.000144	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	0.00014	0.000143	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	9.24e-05	9.44e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	6.04e-05	6.17e-05	CbGpPWpGaD
